1. 1. Mizusawa H, Kishida S, Saijo M, et al. [Progressive multifocal leukoencephalopathy (PML)]. Rinsho Shinkeigaku (Clin Neurol) 51: 1051-1057, 2011 (in Japanese, Abstract in English).
2. 2. Wattjes MP, Wijburg MT, van Eijk J, et al. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. J Neurol Neurosurg Psychiatry 89: 535-541, 2018.
3. 3. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623-625, 1999.
4. 4. Clifford DB, De Luca A, DeLuca A, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9: 438-446, 2010.
5. 5. Neil EC, DeAngelis LM. Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. Blood Adv 1: 2041-2045, 2017.